Literature DB >> 10551268

Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G protein-coupled inwardly rectifying K+ channels.

B Y Ho1, Y Uezono, S Takada, I Takase, F Izumi.   

Abstract

Signaling of the cannabinoid CB1 and CB2 receptors through phospholipase C (PLC) and G protein-coupled inwardly rectifying K+ channels (GIRK) was studied after their expression in COS7 cells and Xenopus oocytes. The CB1 or CB2 receptor was co-expressed with alpha subunits of the Galphaq family (Galphaq, Galpha11, Galpha14, Galpha15 and Galpha16) in COS7 cells. Receptor-dependent activation of PLC was observed after co-expressing the CB1 receptor with Galpha14, Galpha15 or Galpha16 but not with Galphaq or Galpha11. Co-expression of Gbeta1 and Ggamma2 abolished the activation, indicating that the activation was mediated by Galpha. PLC activation was not observed when the CB2 receptor was expressed alone or co-expressed with any of the above Galpha subunits. Coupling to GIRK was observed with both CB1 and CB2 receptors after expression in Xenopus oocytes. Significantly larger currents were induced when the receptor was co-expressed with both GIRK1 and GIRK4 than with either GIRK alone. Co-expression of Galpha transducin with the receptor significantly reduced the K+ currents, indicating that GIRK activation was mediated by Gbetagamma but not by Galpha. These findings suggest two new signaling pathways for the cannabinoid receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551268

Source DB:  PubMed          Journal:  Receptors Channels        ISSN: 1060-6823


  21 in total

1.  Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line.

Authors:  M Begg; A Baydoun; M E Parsons; A Molleman
Journal:  J Physiol       Date:  2001-02-15       Impact factor: 5.182

2.  A pervasive mechanism for analgesia: activation of GIRK2 channels.

Authors:  Y A Blednov; M Stoffel; H Alva; R A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-19       Impact factor: 11.205

Review 3.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 4.  CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?

Authors:  Amey Dhopeshwarkar; Ken Mackie
Journal:  Mol Pharmacol       Date:  2014-08-08       Impact factor: 4.436

Review 5.  Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets.

Authors:  Srikrishnan Mallipeddi; David R Janero; Nikolai Zvonok; Alexandros Makriyannis
Journal:  Biochem Pharmacol       Date:  2016-11-24       Impact factor: 5.858

6.  5-HT1A receptors increase excitability of spinal motoneurons by inhibiting a TASK-1-like K+ current in the adult turtle.

Authors:  Jean-François Perrier; Aidas Alaburda; Jørn Hounsgaard
Journal:  J Physiol       Date:  2003-03-07       Impact factor: 5.182

Review 7.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

Review 8.  The recent progress in research on effects of anesthetics and analgesics on G protein-coupled receptors.

Authors:  Kouichiro Minami; Yasuhito Uezono
Journal:  J Anesth       Date:  2012-10-26       Impact factor: 2.078

9.  Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists.

Authors:  Beatriz Fioravanti; Milena De Felice; Cheryl L Stucky; Karen A Medler; Miaw-Chyi Luo; Luis R Gardell; Mohab Ibrahim; T Phil Malan; Henry I Yamamura; Michael H Ossipov; Tamara King; Josephine Lai; Frank Porreca; Todd W Vanderah
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

10.  Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.

Authors:  A Vanessa Stempel; Alexander Stumpf; Hai-Ying Zhang; Tuğba Özdoğan; Ulrike Pannasch; Anne-Kathrin Theis; David-Marian Otte; Alexandra Wojtalla; Ildikó Rácz; Alexey Ponomarenko; Zheng-Xiong Xi; Andreas Zimmer; Dietmar Schmitz
Journal:  Neuron       Date:  2016-04-28       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.